about
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in malesIncidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men.Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: data from the Global Study of Sexual Attitudes and Behaviors (GSSAB).Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in BrazilSexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continentsPrevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with menSafety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adultsImmunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years oldPhase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial.Glycemic control and diabetes management in hospitalized patients in BrazilDistribution of strain type and antimicrobial susceptibility of Escherichia coli isolates causing meningitis in a large urban setting in BrazilDefinitions/epidemiology/risk factors for sexual dysfunction.Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission.Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials.Correction: Glycemic control and diabetes management in hospitalized patients in Brazil.Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women--results of the Brazilian study on sexual behavior (BSSB).Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction.A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men.Associations among immunological, parasitological and clinical parameters in canine visceral leishmaniasis: Emaciation, spleen parasitism, specific antibodies and leishmanin skin test reaction.Sexual difficulties and help-seeking among mature adults in Australia: results from the Global Study of Sexual Attitudes and Behaviours.Sexual problems and associated help-seeking behavior patterns: results of a population-based survey in France.Comparative analysis of the frequency of lower urinary tract dysfunction among institutionalised and non-institutionalised children.Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial.Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil.Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil.Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial.A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America.Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe.Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey.Lower urinary tract symptoms and erectile dysfunction are highly prevalent in ageing men.The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil.Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors.
P50
Q24614644-45BBAB32-D823-4C36-8287-98C2A2DE4A5EQ30457368-354E5A61-EDD7-46A3-A7B9-7A1A4781BD61Q31032711-EA3DD9FF-4B26-4724-8176-C5782C612B43Q33808461-875174C8-30DB-4461-A3E0-416DDA52EDF5Q34548848-E585A374-BEDA-4A71-B03B-E8D1060C51E4Q34910428-89DD48A2-BE10-4E29-83EB-DD1931BE2FCEQ34910475-0650A93C-BA4B-4CDB-98AF-09AADFD94E53Q35558548-ADFB7534-A0C5-42B6-9DBD-96576D609370Q35739048-9FD71519-4F06-4DC9-AF50-BB24FA2A6F69Q35887777-3445353B-3572-4CA6-B4C9-796D6B8D095FQ36378204-EC2389F3-9590-4362-95AA-1DFD8DEBC57DQ37376834-B2D805B5-7B6C-4DBD-B317-056120D5CBDBQ37713709-42DE0F24-8A58-4121-8D4E-482AEC8DE76AQ37730208-52931B3E-6AD7-46A2-8A2E-0866BD0882F1Q38372521-4D37C3B3-AAEE-491E-832C-8FAE9A41698AQ38673370-17FC2EB5-8EAC-4BCC-A2C0-8A5ECBC366ECQ39409889-00635DF1-9C76-449C-8196-BB715883C76CQ39690269-73162ED2-BB81-47C8-8576-05A2A6658E6BQ39752432-551ED9AD-6803-42DA-819B-4A03B2CC7FB8Q41856013-E6927EDC-4112-4339-9509-A49D80CDD409Q42285579-B3D64BB0-037E-4D99-9FE6-C906EAB3BBFBQ43806003-A592EE4F-3B2F-4BD7-B38F-73709DC347F3Q44297429-3D5B36DC-052C-4161-A7D3-E6F85B1684A7Q44718851-F5E9E024-6FC7-4809-9404-E1B91D7480EAQ45177729-CA0150EF-1327-47F3-A2B7-B07BADC9A3B2Q45181959-11589735-BC2A-48A4-9642-638C1C959088Q45840807-B652C11B-1441-4FF1-89E8-06A6E9F12256Q45923435-157E535E-1528-499B-8A8D-2CE836E0259AQ46333486-4CFAD36D-67FA-40E6-A797-9EDA52F7F274Q47207502-FF708F40-703D-490C-BE05-C0B31D533924Q47264132-570AD414-73E8-416A-92C5-002B02259DB0Q47406524-FCEB7744-8CBD-4500-AEDC-88B464863AE4Q49206733-E9F16A8F-715F-45B6-8CCC-B4F1F5C00DC8Q50789027-4EEB010B-0AE7-4B86-9D48-CCFE0CB2145AQ51654468-13E0C4FC-4BE9-4AE9-8BB3-190898BF2774Q51715876-B74E7C03-4CE9-45BD-A880-04D8FDA697FFQ51828647-1DE09549-EC55-4D20-8342-197160647E17Q53258690-574B6EC7-EFA8-4587-A200-D7ED69507CFEQ53312186-2D6F286A-A0B3-4177-9771-3C8A12CB78AEQ53320365-293E115B-5E05-43CE-BA9B-80C0A094FAE3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Edson D. Moreira
@ast
Edson D. Moreira
@en
Edson D. Moreira
@es
Edson D. Moreira
@nl
Edson D. Moreira
@sl
type
label
Edson D. Moreira
@ast
Edson D. Moreira
@en
Edson D. Moreira
@es
Edson D. Moreira
@nl
Edson D. Moreira
@sl
altLabel
E; Duarte Moreira,Edson Moreir ...... D.; Moreira, Edson D.; Moreira
@en
prefLabel
Edson D. Moreira
@ast
Edson D. Moreira
@en
Edson D. Moreira
@es
Edson D. Moreira
@nl
Edson D. Moreira
@sl
P106
P1153
35599068100
6508375757
P21
P31
P496
0000-0002-7081-8348